• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗信息:如何传递当前的科学数据。VALIDATA 小组]

[Therapeutic information: how to transmit current scientific data. Group VALIDATA].

作者信息

Boissel J P

机构信息

Service de Pharmacologie clinique, Lyon.

出版信息

Therapie. 1994 Jul-Aug;49(4):299-311.

PMID:7878596
Abstract

The information on therapeutics is moving at a high path for various causes. Now, tools for informing correctly the prescriber do exist. However, they require the operation of suitable structures. The mainstem of the system consists of an intermediary which should comply with appropriate rules. It will work from an exhaustive collection of pertinent information. This will allowed by the extensive use of literature data banks and clinical trial registries kept with the help of international collaboration. It will rank the strength of evidence of the collected data according to their internal validity. It will elaborate overviews from validated data obtained from meta-analysis, and messages readily readable by the users, and accessible whenever needed. Overviews will be used to set up guidelines, references, editorials... Data banks will be accessible to researchers, teachers, officers concerned by health care.

摘要

由于各种原因,治疗学方面的信息正快速发展。目前,确实存在能正确告知开处方者信息的工具。然而,它们需要合适结构的运作。该系统的主干由一个应遵循适当规则的中介机构组成。它将基于详尽收集的相关信息开展工作。这借助于文献数据库的广泛使用以及在国际合作帮助下保存的临床试验登记来实现。它将根据收集数据的内部有效性对其证据强度进行排序。它将根据从荟萃分析获得的有效数据精心编制概述,以及用户易于阅读且在需要时可获取的信息。概述将用于制定指南、参考文献、社论……研究人员、教师、医疗保健相关人员都可访问数据库。

相似文献

1
[Therapeutic information: how to transmit current scientific data. Group VALIDATA].[治疗信息:如何传递当前的科学数据。VALIDATA 小组]
Therapie. 1994 Jul-Aug;49(4):299-311.
2
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
3
DEC-net: the development of the European register of clinical trials on medicines for children.DEC-net:欧洲儿童用药品临床试验登记册的发展
Clin Trials. 2006;3(4):366-75. doi: 10.1177/1740774506069154.
4
[Hierarchies according to the level of evidence of source data, before their integration in the synthesis, in the matter of therapeutic efficacy].[在治疗效果方面,源数据在整合到综述之前,根据其证据水平划分的层次结构]
Therapie. 1996 May-Jun;51(3):261-4.
5
[Information system for prescriptors and consumers].[开处方者和消费者信息系统]
Therapie. 1996 May-Jun;51(3):292-7.
6
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.降血压治疗主要随机试验的前瞻性协作综述方案。世界卫生组织 - 国际高血压学会降血压治疗试验协作组
J Hypertens. 1998 Feb;16(2):127-37.
7
Research synthesis and dissemination as a bridge to knowledge management: the Cochrane Collaboration.作为知识管理桥梁的研究综合与传播:考克兰协作网
Bull World Health Organ. 2004 Oct;82(10):778-83.
8
Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.药品不良反应监测与互联网:法国药物警戒中心对互联网使用情况的评估以及对用于收集药品不良反应信息的相关网站的非详尽调查。
Therapie. 1999 Sep-Oct;54(5):525-32.
9
[Drug databank and therapeutic information].[药品数据库与治疗信息]
Therapie. 1996 May-Jun;51(3):246-8.
10
[Comparative study of French drug data banks].
Therapie. 1997 May-Jun;52(3):207-12.